Instructions of the board of directors that this transaction complies with the provisions of Article 4 of the “Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructurings”
The Board's explanation on the completeness of the transaction's compliance with legal procedures and the effectiveness of submitting legal documents
The board of directors explained that the entities involved in this transaction did not have Article 12 of the “Supervisory Guidelines for Listed Companies No. 7 - Supervision of Abnormal Stock Transactions Related to Major Asset Restructurings of Listed Companies” or Article 30 of the “Shanghai Stock Exchange Listed Companies Self-Regulatory Guidelines No. 6 - Major Asset Restructurings”
Explanation of the board of directors on stock price fluctuations in the 20 trading days prior to the date of the first announcement of this transaction
Explanation of the board of directors on the purchase and sale of assets by listed companies within 12 months prior to this transaction
Explanation of the Board of Directors on the confidentiality measures and confidentiality system adopted in this transaction
Instructions of the board of directors that this transaction complies with the provisions of Articles 11 and 43 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”
Explanation of the Board of Directors that this transaction does not constitute a restructuring and listing situation as stipulated in Article 13 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”
The board of directors explained that the transaction complied with the provisions of section 11.2 of the “Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules”, section 20 of the “Measures for the Continued Supervision of Companies Listed on the Science and Technology Innovation Board (Trial)”, and section 8 of the “Shanghai Stock Exchange Listed Company Major Asset Reorganization Review Rules”
Sanyou Healthcare: 2021 Annual Equity Distribution Implementation Notice
2021 Annual Equity Distribution Implementation Notice
Sanyou Medical: Announcement on the Acquisition of Shares and Related Transactions of Participating Subsidiaries
No Data